- Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
-
Fujiwara S, Terai Y, Tsunetoh S, Sasaki H, Kanemura M, Ohmichi M
- KMID: 2345922
- J Gynecol Oncol.
- 2015 Oct;26(4):311-319.
- doi: 10.3802/jgo.2015.26.4.311
OBJECTIVE: There is no research regarding the appropriate antiemetic agents for female patients, especially those receiving moderately emetogenic chemotherapy (MEC). We evaluated the antiemetic efficacy of a combination of 5-HT3... -
- CITED
-
- Close
- SHARE
-
- Close
- A Less Intensive Combination of Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer Patients who Have Aged 60 Years or More and Has a Poor Performance Status
-
Min YJ, Ahn JJ, Noh YJ, Cha HJ, Suh JH, Jung JP, Park CR, Jeong AK, Park JH, Lee KM
- KMID: 759697
- Korean J Intern Med.
- 2004 Jun;19(2):109-113.
BACKGROUND: The aim of this study was to evaluate the response, survival, and toxicities of a less intensive combination of paclitaxel and carboplatin, which is used in advanced non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
-
Mabuchi S, Isohashi F, Okazawa M, Kitada F, Maruoka S, Ogawa K, Kimura T
- KMID: 2413856
- J Gynecol Oncol.
- 2017 Jan;28(1):e15.
- doi: 10.3802/jgo.2017.28.e15
OBJECTIVE: To evaluate the efficacy and toxicity of paclitaxel plus carboplatin (TC)-based concurrent chemoradiotherapy (CCRT) followed by consolidation chemotherapy in the International Federation of Gynecology and Obstetrics (FIGO) stage IIIB/IVA... -
- CITED
-
- Close
- SHARE
-
- Close
